rs2271733
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_013435.3(RAX):c.132C>A(p.Asp44Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 1,534,892 control chromosomes in the GnomAD database, including 61,170 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4596 hom., cov: 33)
Exomes 𝑓: 0.28 ( 56574 hom. )
Consequence
RAX
NM_013435.3 missense
NM_013435.3 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: -0.892
Genes affected
RAX (HGNC:18662): (retina and anterior neural fold homeobox) This gene encodes a homeobox-containing transcription factor that functions in eye development. The gene is expressed early in the eye primordia, and is required for retinal cell fate determination and also regulates stem cell proliferation. Mutations in this gene have been reported in patients with defects in ocular development, including microphthalmia, anophthalmia, and coloboma.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.0028769076).
BP6
?
Variant 18-59273075-G-T is Benign according to our data. Variant chr18-59273075-G-T is described in ClinVar as [Benign]. Clinvar id is 260309.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
?
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RAX | NM_013435.3 | c.132C>A | p.Asp44Glu | missense_variant | 1/3 | ENST00000334889.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RAX | ENST00000334889.4 | c.132C>A | p.Asp44Glu | missense_variant | 1/3 | 1 | NM_013435.3 | P1 | |
RAX | ENST00000256852.7 | c.132C>A | p.Asp44Glu | missense_variant | 1/2 | 1 | |||
RAX | ENST00000555288.1 | c.132C>A | p.Asp44Glu | missense_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.235 AC: 35733AN: 152054Hom.: 4594 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
35733
AN:
152054
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.224 AC: 29462AN: 131492Hom.: 3639 AF XY: 0.230 AC XY: 16383AN XY: 71260
GnomAD3 exomes
AF:
AC:
29462
AN:
131492
Hom.:
AF XY:
AC XY:
16383
AN XY:
71260
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.282 AC: 389830AN: 1382726Hom.: 56574 Cov.: 36 AF XY: 0.280 AC XY: 191322AN XY: 682316
GnomAD4 exome
AF:
AC:
389830
AN:
1382726
Hom.:
Cov.:
36
AF XY:
AC XY:
191322
AN XY:
682316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.235 AC: 35732AN: 152166Hom.: 4596 Cov.: 33 AF XY: 0.228 AC XY: 16964AN XY: 74388
GnomAD4 genome
?
AF:
AC:
35732
AN:
152166
Hom.:
Cov.:
33
AF XY:
AC XY:
16964
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1102
ALSPAC
AF:
AC:
1205
ESP6500AA
AF:
AC:
490
ESP6500EA
AF:
AC:
1484
ExAC
?
AF:
AC:
4013
Asia WGS
AF:
AC:
786
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Isolated microphthalmia 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
MutationTaster
Benign
P;P
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
0.0040
.;B;.
Vest4
MutPred
Gain of methylation at K43 (P = 0.0894);Gain of methylation at K43 (P = 0.0894);Gain of methylation at K43 (P = 0.0894);
MPC
0.75
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at